Form 4: Zimmer Biomet Director Arthur J. Higgins Reports Stock Transactions

Director Arthur J. Higgins reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.

Summary

• Arthur J. Higgins, a director of Zimmer Biomet Holdings, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 10, 2024, Higgins acquired 616.726 phantom stock units at a price of $121.61 each.
• These phantom stock units were accrued under the company's Deferred Compensation Plan for Non-Employee Directors.
• Higgins also acquired 1,068.991 restricted stock units on the same date.
• The restricted stock units are immediately 100% vested but subject to mandatory deferral until the later of Higgins' termination of service as a director or three years after the grant date.
• Following these transactions, Higgins beneficially owns 32,783.401 shares of common stock (including phantom stock units) and 23,452.928 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The acquisition of phantom stock units and restricted stock units aligns the director's interests with the long-term performance of the company.
• The vesting and deferral terms of the restricted stock units encourage long-term commitment from the director.

Future Outlook

The phantom stock units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, stock options, and restricted stock units to align their interests with shareholders.
• The vesting schedules and deferral periods for restricted stock units are common practices to incentivize long-term commitment.
• Companies like Johnson & Johnson and Medtronic also utilize similar compensation structures for their directors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly increasing the number of shares outstanding upon settlement of the phantom stock units.
• The compensation structure for the director can influence their decision-making and strategic direction for the company.

Key Dates